tiprankstipranks
Advertisement
Advertisement

NUVL Stock Latest News

John Newman Reiterates Buy on Neladalkib, Keeps $126 Price Target After Solid ALKOVE-1 PFS Data
RatingsJohn Newman Reiterates Buy on Neladalkib, Keeps $126 Price Target After Solid ALKOVE-1 PFS Data
4d ago
NUVL
Nuvalent announces FDA acceptance of neladalkib NDA, Georg Pirmin Meyer as CIO
PremiumThe Fly
Nuvalent announces FDA acceptance of neladalkib NDA, Georg Pirmin Meyer as CIO
10d ago
NUVL
Bernstein starts Nuvalent with an Outperform, calls it ‘best idea and top pick’
PremiumThe Fly
Bernstein starts Nuvalent with an Outperform, calls it ‘best idea and top pick’
15d ago
NUVL
Nuvalent initiated with an Outperform at Bernstein
PremiumThe Fly
Nuvalent initiated with an Outperform at Bernstein
15d ago
NUVL
Analyst Reiterates Buy on Nuvalent, Sees Best-in-Class Oncology Catalysts and Maintains $126 Price Target
PremiumRatings
Analyst Reiterates Buy on Nuvalent, Sees Best-in-Class Oncology Catalysts and Maintains $126 Price Target
18d ago
NUVL
Nuvalent Maintained at Buy as Advancing Precision Oncology Pipeline Supports Unchanged $126 Price Target
PremiumRatingsNuvalent Maintained at Buy as Advancing Precision Oncology Pipeline Supports Unchanged $126 Price Target
29d ago
NUVL
Nuvalent Earns Buy Rating on De-Risked Late-Stage Pipeline and Multi-Launch Potential Through 2026
Premium
Ratings
Nuvalent Earns Buy Rating on De-Risked Late-Stage Pipeline and Multi-Launch Potential Through 2026
29d ago
NUVL
Nuvalent: Buy Rating Reiterated on Strong Oncology Pipeline, Commercial Readiness, and Unchanged $142 Price Target
Premium
Ratings
Nuvalent: Buy Rating Reiterated on Strong Oncology Pipeline, Commercial Readiness, and Unchanged $142 Price Target
30d ago
NUVL
Nuvalent reports Q1 EPS ($1.39), consensus ($1.31)
PremiumThe Fly
Nuvalent reports Q1 EPS ($1.39), consensus ($1.31)
30d ago
NUVL
Guardant Health announces multi-year strategic collaboration with Nuvalent
PremiumThe Fly
Guardant Health announces multi-year strategic collaboration with Nuvalent
1M ago
GH
NUVL
Nuvalent Buy Rating: Zidesamtinib’s Differentiated ROS1 CNS Efficacy Supports $155 Target Price
PremiumRatings
Nuvalent Buy Rating: Zidesamtinib’s Differentiated ROS1 CNS Efficacy Supports $155 Target Price
2M ago
NUVL
Nuvalent to present preclinical data for zidesamtinib at AACR meeting
PremiumThe Fly
Nuvalent to present preclinical data for zidesamtinib at AACR meeting
2M ago
NUVL
Nuvalent: Buy Rating on Strong Pipeline Execution, Dual NDA Momentum, and Solid Cash Runway in Targeted NSCLC
PremiumRatingsNuvalent: Buy Rating on Strong Pipeline Execution, Dual NDA Momentum, and Solid Cash Runway in Targeted NSCLC
2M ago
NUVL
Nuvalent Files FDA Application for Lung Cancer Therapy
Premium
Company Announcements
Nuvalent Files FDA Application for Lung Cancer Therapy
2M ago
8K
NUVL
Nuvalent submits neladalkib NDA to FDA
Premium
The Fly
Nuvalent submits neladalkib NDA to FDA
2M ago
NUVL
Nuvalent initiated with an Overweight at Wells Fargo
PremiumThe Fly
Nuvalent initiated with an Overweight at Wells Fargo
2M ago
NUVL
De-Risked Oncology Pipeline and Strong Cash Position Underpin Outperform Rating and $125 Target
PremiumRatings
De-Risked Oncology Pipeline and Strong Cash Position Underpin Outperform Rating and $125 Target
3M ago
NUVL
Nuvalent price target raised to $138 from $132 at UBS
PremiumThe Fly
Nuvalent price target raised to $138 from $132 at UBS
3M ago
NUVL
Nuvalent: Buy Rating Backed by Late‑Stage Oncology Pipeline and Upcoming Value‑Driving Milestones
PremiumRatings
Nuvalent: Buy Rating Backed by Late‑Stage Oncology Pipeline and Upcoming Value‑Driving Milestones
3M ago
NUVL
Nuvalent price target raised to $140 from $135 at Cantor Fitzgerald
PremiumThe FlyNuvalent price target raised to $140 from $135 at Cantor Fitzgerald
3M ago
NUVL
Nuvalent reports Q4 EPS ($1.58), consensus ($1.44)
Premium
The Fly
Nuvalent reports Q4 EPS ($1.58), consensus ($1.44)
3M ago
NUVL
Nuvalent files automatic mixed securities shelf
Premium
The Fly
Nuvalent files automatic mixed securities shelf
6M ago
NUVL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >